Types of AD

Clinical ScenarioCore ICD-10 CodesAdd-on Codes/Notes
Early-onset (DIAD/EOAD)G30.0F02.8x, genetic variant in note
Late-onset (LOAD)G30.1F02.8x, note ApoE4 & PRS
Down’s + Alzheimer’sQ90.x + G30.xF02.8x for dementia
Mixed: AD + LBDG30.x + G31.83F02.8x or F03.x
AD + Vascular DementiaG30.x + F01.xF02.8x
AD + Prion DiseaseG30.x + A81.0F02.8x
AD with Herpes SimplexG30.x + B00F02.8x if dementia
AD with Substance UseG30.x + F10–F19F02.8x
Sporadic/Recessive ADG30.8F02.8x
Unspecified ADG30.9F03.x

Definitions

  • AD = Alzheimer’s Disease
  • DIAD = Dominantly inherited Alzheimer’s Disease (APP, Presenilin 1, or Presenilin 2 pathological variants)
  • Trisomy 21 = Down’s Syndrome – resulting in 3 APP genes.
  • ApoE4 homozygotes – EOAD Early Onset Alzheimer’s Disease

Genetic profile , Lifestyle, and Biological Age based Disease Staging

Dementia/Alzheimer’s  Disease Clinical Guidelines

San Diego County Alzheimer’s Project

Request an Online Visit with Dr. Carr for

Cognitive Assessments

Blood Testing,

Imaging or Other Reasons

Request a Personalized Treatment Plan

Healthy Body, Healthy Mind & Tools for Navigating Dementia

Treatment : Mechanism of Action
Omega 3 fatty acids , Superoxide Anion Detoxifiers/Production Inhibitors – Reducing Neuroinflammation
Stimulating Glymphatic Drainage of the Brain during Deep Sleep through prevention of AQP4 delocalization in periarterial Astrocyte Endfeets.
Lithium Orotate – Glycogen Phosphate Kinase beta inhibitor
Polyphenols –Anti Tau and Amyloid beta protein aggregation
Probiotic Nutritional Fibers with enteric microbiome metabolization: Ferulic Acid, Butyrate, and Short Chained Fatty Acids
Womens supplements
Vitamin D3, K2, and Mg – General Nutrition
Vitamin B12 – Brain Nutrients
Anti amyloid protein antibody injections
BACE1 aspartate protease inhibitors,
Plasminogen protein infusions
Acetylcholine Esterase Inhibitors
Incretins – GLP-1 – GIP agonists
Varicella Zoster Vaccine – Vaccinations against Neurotropic Viruses or Bacteria
SGLT2 inhibitors
C1q complement cascade -Inhibitors or Enhancers

Treatments in Development